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All cells respond to extracellular signals by altering their intracellular biochemical state.
In neurons, such signaling regulates many aspects of cell and synapse biology and
induces changes that are thought to be important for nervous system development,
its adaptation in the face of a changing environment, and ongoing homeostatic
maintenance. Although great advances have been made in developing novel fluorescent
reporters of intracellular signaling as well as in methods of fluorescence detection for use
in freely moving animals, these approaches have generally not been combined. Thus,
we know relatively little about how the intracellular biochemical state of neurons, and
other cell classes, is dynamically regulated during animals’ behavior. Here we describe a
single multi-mode fiber based fluorescence lifetime photometry system (FLiP) designed
to monitor the state of fluorescence reporters of biochemical state in freely moving
animals. We demonstrate the utility of FLiP by monitoring the lifetime of FLIM-AKAR, a
genetically encoded fluorescent reporter of PKA phosphorylation, in populations of direct
and indirect pathway striatal projection neurons in mice receiving food rewards. We find
that the activity of PKA in each pathway is transiently regulated by reward acquisition,
with PKA phosphorylation being enhanced and repressed in direct and indirect pathway
neurons, respectively. This study demonstrates the power of FLiP to detect changes in
biochemical state induced by naturalistic experiences in behaving animals.
Keywords: FLIM (fluorescence lifetime imaging microscopy), fiber photometry, PKA, dopamine, accumbens
INTRODUCTION
Neurons in the mammalian brain utilize transmembrane signaling to regulate their intracellular
state in response to extracellular cues. One prominent mode of such regulation is through the
activation of G-protein coupled receptors, which transduce the binding of an extracellular ligand
to liberate effector G-proteins and generate second messengers (Greengard, 2001; Kreitzer and
Malenka, 2008; Chen et al., 2017). Similarly, Ca-permeable ion channels, such as voltage-gated
Ca channels and NMDA-type glutamate receptors, increase intracellular calcium and activate Ca-
dependent signaling cascades (Lee et al., 2009; Herring and Nicoll, 2016). Other extracellular
signals, including neurotrophins, cytokines, and gasses also rapidly induce changes in cellular
biochemical state (Huang and Reichardt, 2001; Regehr et al., 2009; Prieto and Cotman, 2017).
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Such modulation of intracellular signaling by extracellular
signals is central to activity-dependent signaling cascades,
including those that mediate synaptic plasticity, dendritic protein
translation, the regulation of kinases and phosphatases, and gene-
transcription (Nayak et al., 1998; Carvalho et al., 1999; Shaywitz
and Greenberg, 1999; Lau et al., 2004; Skeberdis et al., 2006;
Lee et al., 2009; Kandel, 2012; Yagishita et al., 2014). Thus,
these pathways are thought to be crucial for activity-dependent
circuit formation and refinement during development as well as
for learning, memory formation, and behavioral adaptation in
response to a changing environment (Kandel and Abel, 1995;
Davis, 1996; Beninger and Gerdjikov, 2004; Tronson et al., 2006;
Doll and Broadie, 2014; Jiang and Nardelli, 2016). To understand
how these pathways are activated and how they contribute to
these functions, one would ideally monitor the dynamics of the
upstream activating second messenger (such as Ca or cAMP), the
specific activity of effector enzyme itself (such as the activity state
of a kinase), and the state of the enzyme substrates (such as the
phosphorylation state of a kinase target).
Protein kinase A (PKA) in the striatum has been proposed
to be an essential mediator of dopamine dependent reward-
reinforced behaviors in animals (Beninger and Gerdjikov, 2004;
Kravitz and Kreitzer, 2012). The dorsal striatum and the ventral
striatum nucleus accumbens (NAc) receive dense innervation
from dopaminergic neurons located in the substantia nigra pars
compacta (SNC) and ventral tegmental area (VTA), respectively
(Howe and Dombeck, 2016). Dopamine release in the striatum
is generally triggered by positive action outcomes, such as the
acquisition of water or food, and, through processes that are
still poorly understood, modulates striatal circuits to promote
the repetition of the action that led to the good outcome
(Schultz et al., 1997; Bromberg-Martin et al., 2010; Schultz,
2013). Central to models of dopamine action on the striatum
and reward reinforcement are its differential effects on the two
main classes of striatal projection neurons (SPNs) (Berke and
Hyman, 2000; Shen et al., 2008; Bromberg-Martin et al., 2010;
Kravitz and Kreitzer, 2012). These models propose that dopamine
acting through Gαs-coupled Type 1 dopamine receptors (D1Rs)
expressed by direct pathway SPNs (dSPNs) promotes motor
action and reward reinforcement by activating PKA in these
cells to increase their intrinsic excitability, potentiate synapses,
and induce transcription (Gerfen and Surmeier, 2011; Tritsch
and Sabatini, 2012). Conversely, dopamine acting through Gαi-
coupled Type 2 dopamine receptors (D2Rs) expressed by indirect
pathway SPNs (iSPNs) may induce opposite effects in these cells
(Gerfen and Surmeier, 2011; Tritsch and Sabatini, 2012). These
push-pull actions of dopamine are thought to induce imbalances
in activities and biochemical states of dSPNs and iSPNs that
contribute to reward reinforced learning, drug addiction, and
Parkinson’s disease (Bromberg-Martin et al., 2010; Kravitz and
Kreitzer, 2012). However, due to technical limitations (Goto et al.,
2015; Yamaguchi et al., 2015), the dynamic change of PKA activity
in dSPNs and iSPNs during behavior is unclear, and thus basic
tenets of this model remain untested.
Here, we developed a system to monitor PKA signaling in
genetically-defined neurons, such as dSPNs and iSPNs, in freely
behaving mice. We exploit a genetically encoded sensor for
PKA, FLIM-AKAR (Chen et al., 2014), which contains a GFP-
based fluorophore whose lifetime in the excited state changes
when the reporter is phosphorylated by PKA. In order to use
this sensor in freely moving mice, we designed a single optical
fiber system for fluorophore lifetime measurements, building
on the previous work that used a pair of optical fibers to
monitor the static lifetime of a genetically encoded fluorophore
in vivo (Cui et al., 2013, 2014). We refer to this approach
as Fluorescence Lifetime Photometry (FLiP). We validated this
approach by performing bulk measurements of fluorophore
lifetime change in vivo and demonstrate the ability of FLiP
to detect dynamic modulation of PKA activity in the NAc.
Our results demonstrate that environmental signals, such as
the acquisition and consumption of food, trigger brief and
opposing PKA phosphorylation transients in dSPNs and iSPNs.
We propose that FLiP can be used with other fluorescence
lifetime reporters of biochemical pathways and is a powerful tool
for monitoring intracellular biochemical states in vivo.
RESULTS
Analysis of Fluorescein Standards Using
2P-FLIM and FLiP
A previous study by Cui et al. (2013) measured the fluorescence
lifetime of a fluorophore in the brain of a mouse using a dual
fiber photometry system in which a single-mode fiber delivered
excitation light into the brain and a multi-mode fiber collected
light in the brain. The rationale behind this design was that a
single-mode fiber provides more stable illumination than a multi-
mode fiber, making it more suitable for excitation. Conversely,
a multi-mode fiber has higher light collection efficiency than
a single-mode fiber, making it more suitable for fluorescence
collection. Since it is difficult to launch a free space laser
into a single mode fiber, and two fibers are bulky and more
damaging when inserted into the brain, we examined if bulk
fluorescence lifetime measurements could be made through a
single multimode fiber. In addition, we examined if the sensitivity
of such a system was sufficient to detect small changes in
fluorescence lifetime of a FÖrster resonance energy transfer
(FRET)-based reporter of an intracellular biochemical signal in
freely moving animals.
To test these possibilities, we built a FLiP system that relays
pulsed excitation light to an optical fiber and detects fluorescence
emission by time correlated single photon counting (Figure 1).
The FLiP setup was versatile and could be used with either
a pair of multi-mode optical fibers for independent excitation
and emission paths or with a single multi-mode optical fiber
for both excitation and emission light. We used the setup to
measure the lifetime of fluorescein in a standard solution and
compared the measurements to those made by a conventional
2-photon fluorescence lifetime imaging microscope (2P-FLIM)
(Figure 2A). On average, the lifetime of a fluorescein standard
was underestimated by FLiP (3.4–3.8 ns) compared to with 2P-
FLIM (4.1 ns) (Figures 2B,C). This deviation likely arises from
the contribution of fiber autofluorescence, which has a shorter
lifetime [2.7 ± 0.1 ns (SD), n = 6, measured by launching laser
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FIGURE 1 | Schematics of 1 and 2 fiber fluorescence lifetime photometry
system. A 473 nm pulsed laser (blue) was attenuated using a rotating neutral
density filter (ND) and focused into a fiber optic (F1) patch cord using
steerable mirror M1 and lens L1. For the 1-fiber based method, fluorescence
was collected through the same fiber (F1) using lens L1. Emission light was
separated from the excitation light using dichroic D1 (488 LP) and a
517/20 nm emission filter before focusing the fiber face on a photomultiplier
tube (PMT1) by L2. The patch cord was connected to the single fiber optic
implant inserted into the brain. For the 2-fiber based method, a dual fiber optic
implant was used and connected to F1, which was used solely for excitation,
and to a second fiber optic (F2) patch cord used to collect fluorescence. The
F2 fiber face was imaged onto a PMT (PMT2) using lens L3 and L4 which
were separated by a 517/20 nm emission filter. In each case, the PMT was
connected to a time correlated single photon counting board.
through the fiber into an optical dump] than fluorescein. It is
also possible that because 2P-FLIM excitation light is focused
onto a very small volume of fluorescein solution, it may quickly
bleach fluorophore molecules and effectively prevent homo-
FRET. Since the fiber-based methods distribute excitation light
to a large volume of fluorescein solution, they may suffer more
from autoquenching.
We measured lifetimes with FLiP with optical fibers directly
inserted into the fluorescein solution or with an implant that
would normally be placed in the brain (Figures 2B,C, “w/
implant” vs. “w/o implant”). For both the single and dual fiber
systems, the addition of the implant lowered the lifetime further,
likely reflecting additional autofluorescence of the fiber and the
glue in the fiber optic implant.
These measurements revealed that the single fiber setup with
a fiber implant reported a fluorescein lifetime measurement
closer to the 2P FLIM value than the double fiber setup with
a fiber implant, suggesting that the double fiber system does
not provide a significant advantage over a single fiber system.
Overall, fluorescein lifetime measurements demonstrate that a
single multi-mode fiber-based lifetime measurement can measure
a lifetime close to a true value in a stable manner [3.55 ± 0.02
ns (SD) of fiber measurements vs. 4.13 ± 0.06 ns of 2P FLIM
measurements, n = 6]. Nevertheless, measuring the absolute
lifetime of the targeted fluorophore may be more challenging
with FLiP than with 2P-FLIM because of the contribution of
fiber autofluorescence as well as the larger contribution of tissue
autofluorescence to FLiP measurements (compared to that from
a small excitation volume in 2P-FLIM). However, this is not a
limitation for many studies in which changes in fluorescence
lifetime will be used to measure dynamic engagements of a
biochemical pathway in vivo.
FLiP Can Detect Dopamine Receptor
Driven Activation of dSPN PKA Activity
in vivo
To test if single fiber FLiP can detect a biologically meaningful
signal, we used it to measure the lifetime of a PKA activity
reporter (FLIM-AKAR) that we previously developed (Chen
et al., 2014). Briefly, FLIM-AKAR is a FRET-based PKA
activity reporter consisting of a donor fluorophore and a
FIGURE 2 | Comparison of fluorescence lifetimes across measurement modalities. (A) Schematics of methods used to measure the fluorescence lifetime of
fluorescein in solution (4 µg/ml). Lifetime was measured from a droplet under the objective of a 2 photon fluorescence lifetime imaging microscope (2-photon) using
pulsed 920 nm excitation. In addition, the fiber optic based setups described in Figure 1 were used to measure lifetime with the fiber ends dipped into the
fluorescein solution. (B) Average fluorescence lifetimes measured with the arrangements schematized in (A). The 1- and 2-fiber measurements were made with and
without the patch cord connected to the corresponding implants that are normally inserted into the brain. The results of each of 6 measurements (dots) as well as
the averages and SDs are shown (lines). (C) Example fluorescence lifetime histograms for each recording color-coded as in (B).
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dark acceptor. When the conformation of the sensor changes
due to its phosphorylation by PKA, it brings the donor
and the acceptor closer together, enhancing intramolecular
FRET and reducing the fluorescence lifetime of the donor.
We have shown that, when monitored by 2P-FLIM, FLIM-
AKAR fluorescence lifetime decreases upon PKA activation and
increases upon PKA inactivation in neurons in brain slices
(Chen et al., 2014).
We expressed FLIM-AKAR in dSPNs in the NAc by injecting
an adeno-associated virus (AAV) that expressed the sensor in a
Cre-dependent manner (AAV-FLEX-FLIM-AKAR) into Drd1a-
Cre mice and implanted a single optical fiber into the NAc
(Figure 3A). After 2 weeks of expression of the reporter virus,
we injected a Type 1 dopamine receptor (D1R) agonist (SKF
81297 hydrobromide, 10 mg/kg IP) and measured the lifetime
change in the fluorescence signal collected from the NAc in
freely moving animals. The fluorescence lifetime of FLIM-AKAR
showed a significant reduction (∼0.15 ns) suggesting an increase
in PKA activity in dSPNs after D1R agonist injection (Figure 3B).
The magnitude of the lifetime change was comparable to that
FIGURE 3 | Type 1 dopamine receptor agonists increase PKA phosphorylation in NAc dSPNs. (A) Schematic of a coronal section at 1.2 mm depicting viral injection
of AAV-FLEX-FLIM-AKAR into the NAc of a Drd1a-Cre mouse. An optical fiber was implanted 200 µm above the injection site. (B) Changes in fluorescence lifetime
of FLIM-AKAR expressed in dSPNs of a Drd1a-Cre mouse that was intraperitoneally (IP) injected with a Type 1 dopamine receptor (D1R) agonist. The changes over
time in fluorescence lifetime measured in 1-s interval relative to the baseline (pre-injection) period are plotted. The time when the injection finished is indicated by the
dashed vertical line. For FLIM-AKAR (red), a decrease in lifetime represents an increase in phosphorylation by PKA. A similar measurement was made using
FLIM-AKART391A which has a point mutation at the PKA phosphorylation site (black). For the sensor and mutant sensor, the average responses (line) and SEM
(shaded regions) across seven mice are shown. (C) As in (B), the responses of FLIM-AKAR (red) and the phosphorylation site mutant FLIM-AKART391A (black) to IP
injection of saline. For each, data collected across four mice are shown. (D) Experimental design for using virally-transduced PKI to validate the specificity of the
FLIM-AKAR lifetime changes in dSPNs following D1R agonist injection. A Drd1a-Cre mouse was first injected with AAV-FLEX-FLIM-AKAR to express the reporter in
dSPNs (left). After 2 weeks had elapsed to achieve strong expression of the reporter, the same mouse and region were injected with AAV-FLEX-PKIalpha-IRES-nls-
mRuby2 (middle). An optical fiber was implanted during the same surgery used for the second viral injection. The responses to IP D1R agonist injection were
measured (right) over the subsequent 1–12 days. (E) D1R agonist induced changes in FLIM-AKAR lifetime across multiple days from example mice injected with
high (left) or low (1/10th of high, right) titer PKI virus. (F) The amplitudes of D1R agonist induced changes in FLIM-AKAR lifetime relative to that on day 1 across
multiple days for high (red, n = 3 mice) and low (black, n = 4 mice) titer PKI virus groups. Error bar = SEM.
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observed previously in brain slices with activation of PKA
(Chen et al., 2014).
The D1R-agonist induced fluorescence lifetime change did not
occur in mice expressing a mutant reporter (FLIM-AKART391A)
in dSPNs, which has a point mutation at its consensus PKA
phosphorylation site (Figure 3B). This demonstrates that the
phosphorylation of the sensor at this site is required for the
observed lifetime change. Furthermore, IP injection of saline did
not produce a comparable transient, suggesting that the lifetime
change in D1R agonist experiments is due to the effect of the
drug rather than a general stress caused by scruffing and injection
(Figure 3C). Interestingly, there was a small but significant
change in FLIM-AKAR lifetime at the time of D1R agonist or
saline IP injection that was much smaller and shorter-lived than
the long-lived D1R agonist response. This small signal was not
seen in FLIM-AKART391A expressing mice suggesting that there
is a general effect of IP injection that increases dSPN PKA activity.
To further validate the specificity of the reporter fluorescence
lifetime change in vivo, we employed PKI, which is one of the
most specific inhibitors of PKA currently available (Dalton and
Dewey, 2006; June, 2012). We had previously developed an AAV
that expresses PKI in a Cre-dependent manner (Chen et al.,
2014), allowing specific antagonism of PKA in a genetically-
defined population. We first injected AAV-FLEX-FLIM-AKAR
into the NAc of a Drd1a-Cre mouse and waited 2 weeks to
achieve stable expression of the reporter (Figure 3D). We
subsequently injected AAV-FLEX-PKIalpha-IRES-nls-mRuby2
into the same location and performed fiber implantation. This
approach allowed us to measure PKA dynamics in dSPNs as PKI
expression increased starting the day after fiber implantation (day
1). During days 1–12, we have repeated IP delivery of D1R agonist
and observed a gradual decrease in the magnitude of the evoked
signal over time. With a high PKI virus titer cohort, the D1R
agonist response was eliminated by day 10 (Figures 3E,F). With a
10-fold lower PKI virus titer cohort, the D1R agonist response
was reduced to 30% of its amplitude on day 1 (Figures 3E,F).
This reduction in FLIM-AKAR response is likely caused by the
intended PKI effect of PKA inhibition as post hoc histological
analysis showed minimal signs of neuronal death and confirmed
expression of FLIM-AKAR.
Thus, given its dependence on PKA phosphorylation site and
its blockade by PKI expression, we conclude that D1R-agonist
induced decrease in FLIM-AKAR lifetime reflects bona fide
activation of PKA in dSPNs. Furthermore, these results confirm
the ability of FLiP to report dynamic modulation of endogenous
biochemical signaling cascades in genetically-defined neurons in
freely moving animals.
FLiP Can Detect Modulation of PKA
Activity in dSPNs and iSPNs Induced by
a Natural Stimulus
Although the D1R agonist experiment is a good proof-of-
principle test for FLiP, the result of this experiment does not
guarantee that the system will be able to pick up a change in PKA
activity caused by a natural stimulus, which is likely to be smaller
than the long-lasting effect of D1R agonism. Natural stimuli may
induce signals that are more similar in kinetics and amplitude
to the signals seen following IP saline injection (Figure 3C).
Therefore, we tested if FLiP can detect changes in PKA activity
in dSPNs and iSPNs in mice that receive a food reward. To
compare PKA dynamics in dSPNSs and iSPNs, we expressed
FLIM-AKAR in each population using Drd1a-Cre and Adora2a-
Cre mice, respectively (Figure 4A). Two-three weeks after virus
injection and fiber implantation, mice were food restricted for at
least 1 day before the food reward response was measured. We
subsequently measured the change in the fluorescence lifetime
of FLIM-AKAR in these mice when we gave them a small food
pellet (20 mg) from a food receptacle in an otherwise empty
chamber. Access to food in these mice was expected to elicit a
dopamine transient in the NAc, resulting in subsequent activation
Gαs-coupled dopamine receptors on dSPNs and Gαi-coupled
dopamine receptors on iSPNs.
Indeed, FLIM-AKAR lifetime measured in Drd1a-Cre mice
significantly decreased at the time of food consumption, as
expected from an increase in dSPN PKA activity (Figure 4B).
FIGURE 4 | Food rewards rapidly increase and decrease PKA phosphorylation in dSPNs and iSPNs, respectively. (A) Schematic of a coronal section at 1.2 mm
depicting viral injection of AAV-FLEX-FLIM-AKAR into the NAc of a Drd1a-Cre or Adora2a-Cre mice. An optical fiber was implanted 200 µm above the injection site.
(B) Fluorescence lifetime changes of FLIM-AKAR (red) expressed in a dSPNs in Drd1-Cre mice (left) or iSPNs in Adora2a-Cre mice (right) when the animals were
given a food reward (dashed vertical line = time point of food pellet receptacle entry). The mice were food restricted at least a day before the food reward response
was measured. The patterns show an increase in PKA phosphorylation in dSPNs (n = 4 mice) and a decrease in iSPNs (n = 5 mice). No change is seen in mice
expressing FLIM-AKART391A (black) in either dSPNs (n = 3 mice) or iSPNs (n = 4 mice). Shaded area = SEM of averages across mice. For each mouse, data were
collected across 10 trials.
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Conversely, FLIM-AKAR lifetime in Adora2a-Cre mice increased
at the time of food consumption, marking a reduction in
PKA activity in iSPNs (Figure 4B). Neither signal was seen in
mice expressing FLIM-AKART391A, confirming that the lifetime
changes observed in FLIM-AKAR expressing animals on food
consumption did not come from movement artifacts or changes
in tissue autofluorescence.
The opposite changes in PKA activity in dSPNs and iSPNs are
consistent with expected phasic dopamine release at the time of
unexpected reward delivery leading to activation and suppression
of PKA in each neuron class, respectively. Furthermore, these
results demonstrate the utility of FLiP in monitoring changes
in PKA activity in situ triggered by physiological stimuli in
behaving animals.
Expression of FLIM-AKAR Minimally
Perturbs PKA Activity Dynamics
A concern with reporters of physiological processes is that
their expression may perturb the process of interest. For
example, expression of a phosphorylation substrate could slow
phosphorylation or dephosphorylation if kinases or phosphatases
are in rate-limiting quantities. Such effects are typically seen
as slowing of the signal as the levels of the reporters are
increased. To examine if the expression of FLIM-AKAR
perturbs the dynamics of PKA-dependent phosphorylation, we
performed multi-day measurements of FLIM-AKAR lifetime
changes in response to a food reward as the level of the
reporter increased.
We injected AAV-FLEX-FLIM-AKAR into Drd1a-Cre mice
(Figure 5A) and, after 3 days of surgery, started food restriction
on the mice. Starting on the day after the beginning of
food restriction, we measured FLIM-AKAR lifetime changes
in response to a food reward across multiple days as the
expression of FLIM-AKAR increased. The increase in FLIM-
AKAR expression was estimated from the basal level of
fluorescence under constant excitation power (Figure 5B),
which underestimates the true fold change in the reporter
expression as it ignores that some fraction of the fluorescence
arises from autofluorescence of the fiber and tissue. The daily
average lifetime plot (averaged from five mice) showed no
significant slowing of the dSPN PKA activity dynamics reported
by FLIM-AKAR (Figures 5C,D), even as the amplitude of the
lifetime change increased over an ∼3-fold. Furthermore, from
day to day, there was no strong positive correlation between
normalized photon counts and the time to maximal deviation
from baseline (20–80% baseline to peak, R2 = 0.00078), the time
to return to baseline (80–20% peak to baseline, R2 = 0.12), or
the half-width of the signal (R2 = 0.012) (Figure 5D). Overall,
we find no sign of limiting of PKA or phosphatase activity
caused by the sensor expression. Of note, the fact that the
fluorescence lifetime response increases between day 4∼day10
and stabilizes after day 10 suggests that an accurate and stable
measurement of fluorescence lifetime change requires a certain
level of fluorophore concentration, which ensures the majority
of the detected photons come from the sensor rather than the
background (fiber and tissue autofluorescence).
DISCUSSION
Although many reporters of intracellular second messengers
and their downstream signaling cascades have been developed,
relatively little is known about the dynamic change of
intracellular biochemical signaling other than calcium during
behavior. Fluorescence lifetime imaging microscopy (FLIM), a
FRET-based imaging approach, has been extensively used to
study intracellular signaling in neurons ex vivo (Yasuda et al.,
2006; Lee et al., 2009; Laviv et al., 2016; Chen et al., 2017; Tang and
Yasuda, 2017). FLIM relies on detecting inter- or intra-molecular
interactions between a donor and acceptor fluorophore through
the FRET dependent change in the fluorescence lifetime of
the donor. Genetically-encoded FLIM-compatible reporters have
been developed for many kinases and second messengers (Yasuda
et al., 2006; Lee et al., 2009; Klarenbeek et al., 2011; Chen et al.,
2014; Laviv et al., 2016; Tang and Yasuda, 2017; Colgan et al.,
2018; Ma et al., 2018). Inspired by these studies, we developed
a single multimode fiber-based method to monitor intracellular
signaling in freely-moving mice. We used fluorescence lifetime
photometry (FLiP) to examine the dynamics of protein kinase A
(PKA) signaling in specific population of neurons in the NAc.
The PKA activity reporter that we used, FLIM-AKAR, has been
heavily optimized for fluorescence lifetime measurements in the
previous study (Chen et al., 2014). We demonstrate that FLiP,
using a multimode fiber for both the fluorescence excitation and
emission path, provides stable and reproducible measurements
of the fluorescence lifetime of FLIM-AKAR. Furthermore, we
were able to reveal modulation of the PKA phosphorylation state
following pharmacological and behavioral stimuli, confirming
the sensitivity of the approach to detect dynamics of intracellular
biochemical signaling in behaving mice.
Single Fiber FLiP
The comparison of the lifetimes of a fluorescein standard
measured by FLiP to those measured by 2P-FLIM shows that fiber
photometry systematically underestimates lifetimes. We suggest
that this is likely due to autofluorescence present in the fiber optic,
which typically has a shorter lifetime (∼2.7 ns) than fluorescein
(∼4.1 ns). This conclusion is supported by the finding that adding
the brain fiber implant to the end of the patch cord lowers
the measured lifetime further, likely reflecting the additional
fluorescence derived from this device. Nevertheless, utilizing a
single multimode fiber for excitation light delivery to the brain
and collection of fluorescence from the brain, we were able to
measure a biologically meaningful fluorescence lifetime change.
Our results demonstrate that single-fiber FLiP is able to detect
pharmacologically- and behaviorally-induced changes in PKA-
dependent phosphorylation in genetically-defined populations of
neurons in the NAc. Based on the results presented above, we
propose that the relatively simple single-fiber system presented
here provides a powerful method for the analysis of intracellular
signaling cascades in behaving animals.
Comparison to Other Approaches
Real-time reporters of biochemical processes typically rely on
intra- or inter-molecular conformational changes induced by
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FIGURE 5 | Expression of FLIM-AKAR minimally perturbs PKA activity dynamics. (A) Schematic of the experimental design for testing the effects of FLIM-AKAR
expression levels on response kinetics. First, a Drd1a-Cre mouse was injected with AAV-FLEX-FLIM-AKAR intracranially and was implanted with a fiber. After 3 days
of recovery, the mouse was started on food restriction. Starting on day 4 after surgery (1 day after the beginning of food restriction), food induced changes in lifetime
of FLIM-AKAR expressed in dSPNs were measured for 10 days. After 10 days, the fluorescence intensity reached its maximum for all mice, suggesting viral sensor
expression had reached its maximum (B). (B) Average photon counts of FLIM-AKAR fluorescence under the fixed excitation power across multiple days, normalized
for each mouse by its maximum photon count. Error bar = SEM across n = 5 mice. (C). Average food-induced change in lifetime of FLIM-AKAR expressed in dSPNs
of Drd1a-Cre mice across days. The dashed vertical line indicates the time when the animals entered the food pellet receptacle. Shaded area = SEM across n = 5
mice. For each mouse, data were collected across 6–10 trials/day. (D) For each mouse on each day, the FLIM-AKAR response kinetics were quantified by
measuring the time required for the signal to reach 80% of the maximum valley amplitude from 20% of the maximum valley amplitude (20–80% baseline to peak)
(left) and the time to return to 20% of the maximum valley amplitude from 80% of the maximum valley amplitude (80–20% peak to baseline) (middle). In addition, the
halfwidth (right) of the FLIM-AKAR lifetime response was measured. Each parameter is plotted as a function of the baseline fluorescence photon counts measured in
each mouse for each day during periods when the animal was not eating. N = 5 mice with 6–10 trials acquired for each data point. Measurements were analyzed
when the fluorescence intensity reached 30% of its maximum as they were too noisy at lower intensities.
an enzymatic modification, such as phosphorylation, or binding
of a bioactive molecule. Some reporters, such as GCaMP, alter
their brightness on activation due to a change in absorption
cross-section or quantum yield, which typically does not alter
the fluorescence lifetime of the fluorophore. These reporters
are usually monitored using a single excitation and emission
wavelength. When these reporters are used with fiber photometry
to collect bulk signals in moving animals, care is needed to
ensure that fluorescence dynamics reflect the target biological
processes, as opposed to fluorescence changes induced by
movement of the optical fiber, changes in pH in the tissue,
or hemodynamic alterations that affect photon absorption and
scattering (Hires et al., 2008; Cui et al., 2013; Valley et al., 2019).
On the other hand, with two-color FRET sensors, the
fluorescence intensities of the acceptor and the donor are
both monitored, and their ratio is calculated to deduce
changes in biochemical states. Such approach is difficult to
implement in vivo, as many factors, such as differential bleaching
of each fluorophore, overlap in the emission or excitation
spectra, differential sensitivity of each spectrum to hemodynamic
changes, and differential contribution of autofluorescence to each
emission spectrum, will alter the ratio of donor and acceptor
fluorescence intensity.
For FRET-based FLIM reporters, activation of the biochemical
process alters the fluorescence lifetime of the donor fluorophore,
which allows their monitoring by FLiP and other lifetime
detection methods. Single fluorophore FLIM method avoids
many of the complications of two-color FRET method mentioned
above as the FLIM measurement – fluorescence lifetime of the
donor – is in principal independent of the concentration of the
donor molecules, the excitation efficiency that depends on change
in illumination, and the efficiency with which the fluorescence is
collected. In practice, this holds true as long as the contribution
of background fluorescence to the detected signal is minimal
compared to that of the sensor (the majority of the detected
photons come from the donor fluorophore).
Fluorescence lifetime imaging microscope and, by extension,
FLiP are not impervious to artifacts, and controls for the
specificity of observed lifetime transients need to be established
as they were done here using a variety of controls. Of particular
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concern is the non-negligible contribution of autofluorescence
from the optical fiber, which can affect the measured fluorescence
lifetime if the reporter is dim or rapidly bleaching, compared
to the autofluorescence. In our experience, this concern can
be avoided by using low excitation light levels that minimize
reporter bleaching. Nevertheless, because of the contribution
of autofluorescence, we avoid translating absolute lifetime
measurements into ratios of active and inactive reporter, as
it is often done with low-background imaging modalities
such as 2P-FLIM.
PKA Dynamics in the NAc
We find that pharmacological activation of Type 1 dopamine
receptors (D1Rs) using peripheral administration of an agonist
induces robust and long-lived (>20 min) increases in PKA
dependent phosphorylation in D1R-expressing dSPNs of the
NAc. This is consistent with the GPCR biology of D1Rs:
they couple to Gαs to increase cAMP concentration and thus
activate PKA. The dependence of the reporter response on
the PKA phosphorylation site of the reporter and its blockade
by expression of PKI, demonstrate that the reporter response
results from PKA phosphorylation of FLIM-AKAR. As D1Rs
couple through Gαs to increase cAMP concentration and
thus activate PKA, this was the expected result. In addition
to confirming the sensitivity of fiber-based measurements of
fluorescence lifetime in vivo, these data reveal the in vivo
pharmacokinetics of SKF 81297 hydrobromide, which is widely
used in behavioral experiments. Because FLIM-AKAR can report
orders-of-magnitude briefer (∼20 s) behaviorally triggered PKA
transients (see below), the kinetics of PKA activation reported by
the sensor following D1R agonism likely reflect the duration of
exposure of NAc dSPNs to the drug. We propose that analysis of
biochemical state using in vivo FLiP can be an important tool to
determine the brain penetrance, exposure time, or mechanism of
action of drugs targeting the central nervous system.
Delivery of a reward, in the form of a food pellet to food-
restricted animals, transiently increases and decreases PKA
activity in dSPNs and iSPNs in the NAc, respectively. These
opposite changes are predicted based on the expression of Gαs-
and Gαi-coupled receptors in dSPNs and iSPNs, respectively.
As the kinetics of these signals are not artificially prolonged by
the level of reporter expression, they provide an estimate of the
kinetics of combined PKA/phosphatase action on diffusible PKA
substrates in the cell. Thus, food reward induced changes in
PKA dependent phosphorylation in dSPNs and iSPNs, for ∼40
and ∼20 s, respectively, which provides an upper estimate of
the kinetics of the intracellular biochemical change. In addition,
we find that rewards lower phosphorylation state in iSPNs,
confirming that, in these cells, there is a basal phosphorylation
of PKA substrates, which can be reversed by inhibition of
adenylyl cyclases via Gαi-coupled GPCRs such as Type 2
dopamine receptors.
Summary and Outlook
The fluorescence lifetime photometry system described here is
relatively simple to implement. As it is based on a single multi-
mode fiber, it is compatible with low cost launches that couple the
laser into the fiber. Future improvements may include replacing
the expensive time correlated single photon counting boards
with more affordable high-speed field-programmable gate arrays
(FPGAs) that are more flexible and do not suffer from dead
time, which can increase sampling rates. The system presented
here can detect behaviorally and pharmacologically induced
transients in intracellular biochemical state in genetically-defined
neurons. Thus, it will permit further studies of the intracellular
biochemical mechanisms of many brain processes, such as
those linking experience to cellular plasticity, mediating activity
dependent circuit regulation, and by which hormonal and
metabolic signals influence cellular states.
MATERIALS AND METHODS
Experimental manipulations were performed in accordance with
protocols approved by the Harvard Standing Committee on
Animal Care following guidelines described in the US National
Institutes of Health Guide for the Care and Use of Laboratory
Animals. Inhaled isoflurane was used as anesthesia.
2-Photon Fluorescence Lifetime Imaging
Microscopy (2P-FLIM)
2-Photon fluorescence lifetime imaging microscopy (Figure 2)
was carried out using a custom microscope as previously
described (Chen et al., 2014). 920 nm excitation light (Chameleon
Vision II, 80MHz, Coherent, Santa Clara, CA, United States)
was used to 2-photon excite fluorescein dissolved in water, and
resulted fluorescence was collected in the 500–550 nm bank using
a 525/25 nm emission filter (Semrock) and a PMT (H7422-
40 MOD Hamamatsu).
Fluorescence Lifetime Photometry (FLiP)
Fluorescence lifetime photometry was carried out as illustrated
in Figure 1. All filters in the system were made by Semrock.
The 473 nm laser BDS-473-SM-FBE [Becker and Hickl (BH)]
operated at 50 Mhz was used as a pulsed light source. For
detection, a high speed hybrid PMT, HPM-100-07-Cooled (BH)
controlled by DCC-100-PCI (BH) was used. The PMT was
connected to SPC-830 (BH), a time correlated single photon
counting (TCSPC) board, which detects the time delay between
the pulsed excitation and the photon detection by the PMT.
The data was collected by a custom software in MATLAB,
which calculated the average lifetime of detected photons at 1
s intervals. This interval for average lifetime measurements was
empirically determined to have enough photons to accurately
estimate the lifetime (>200,000 photons/measurement) without
running into a photon count limit (<1,000,000 photons/s) of the
TCSPC board. The typical excitation power needed to generate
an appropriate amount of photons for TCSPC was 0.6∼1 µW
(measured at the output end of the patch cord).
For the estimation of the absolute lifetime of a fluorescein
solution standard (Figure 2), we fit a single exponential decay
to the lifetime histogram. For the data presented in Figure 2,
we used the time constant of this single exponential decay as the
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measure of lifetime. For the estimation of the change in lifetime
of the sensor in vivo (Figures 3–5), we calculated, for each 1 s
time bin, an average lifetime by measuring the mean photon
arrival time (the population mean of the delay between the
pulsed excitation and the fluorescence photon arrival as described
in the equation below), as discussed in the previous study by
Lee et al. (2009).
τm| =< t > −t0 =
∫
dt · tF(t)
dt · F(t) − t0
Here, F(t) is the photon count of a fluorescence lifetime decay
curve at time bin t, and t0 is the offset of the lifetime histogram,
which can be estimated by fitting a double exponential curve to a
lifetime histogram once in the beginning of the experiment.
For this calculation, we chose a time range (0–8 ns) in
a lifetime histogram that was minimally contaminated by a
secondary fluorescence peak created by the autofluorescence of
a fiber. The length of the patch cord was chosen to maximize
the time separation between the sensor fluorescence peak and the
fiber autofluorescence peak (∼10 ns time delay for light to travel
from the one end of the patch cord to the other end and back).
The lifetime of each fluorophore was reported as a change in
lifetime (delta lifetime), which was calculated by subtracting the
average lifetime of a baseline period (a period in graphs before the
event of interest) from the average lifetime transient.
Surgery
Drd1a-Cre or Adora2a-Cre mice with C57BL/6J background
from MMRRC UC Davis were used for all in vivo experiments.
AAV1-FLEX-FLIM-AKAR (2.14 × 1013 gc/ml, 300 nl), AAV1-
FLEX-FLIM- FLIM-AKART391A (7.67 × 1012 gc/ml, 300 nl),
AAV-FLEX-PKIalpha-IRES-nls-mRuby2 (3.72 × 1013 gc/ml for
low titer and 3.72 × 1014 gc/ml for high titer, 600 nl) were
stereotactically injected at+1.2 mm (A/P),+1.3 mm (M/L) from
bregma at a depth of 4.1 mm from brain surface. A fiber optic
implant (MFC_200/230-0.37_4.5mm_MF1.25_FLT mono fiber
optic cannula or DFC_200/245-0.37_5.5mm_DF0.7(2.5)_FLT
dual fiber optic cannula from Doric Lenses) was implanted at the
same coordinate at a depth of 3.9 mm from the brain surface. The
dual fiber optic implant was custom made to place the two fibers
adjacent to each other without any gap and thus to maximize the
overlap between the excitation and collection volumes.
Pharmacology
SKF 81297 hydrobromide (10 mg/kg mixed in 0.1 ml of
saline/10 g of mouse) was injected intraperitoneally (IP) to
activate Type 1 dopamine receptors (D1R) (Figure 3). Saline
(0.1 ml of saline/10 g of mouse) was injected IP for the
controls trials.
Behavior
A mouse connected to a patch cord was allowed to freely
move in an 8 × 16 inch behavior box, which contained a
pellet receptacle in one wall. Receptacle entry was detected
by an infrared sensor installed inside the receptacle. The time
of beam break was used to align the fluorescence lifetime
measurements across trials and to analyze changes in lifetime
caused by food rewards.
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